Bacteria as the cause of ulcerative colitis

[1] [Anonymous], GUT

[2] AZADKHAN AK, 1977, LANCET, V2, P892

[3] BAMBA T, 1995, J GASTROENTEROL, V30, P45

[4] ULCERATIVE-COLITIS AND ESCHERICHIA-COLI WITH ADHESIVE PROPERTIES [J]. JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (07) : 782 - 786

[5] ADHESIVE ESCHERICHIA-COLI IN INFLAMMATORY BOWEL-DISEASE AND INFECTIVE DIARRHEA [J]. BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6641): : 102 - 104

[6] BURKE DA, 1990, ALIMENT PHARM THERAP, V4, P123

[7] Campieri M, 1999, FALK SYMP, V106, P297

[8] Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative? [J]. GASTROENTEROLOGY, 1999, 116 (05) : 1246 - 1249

[9] CONTROLLED TRIAL OF INTRAVENOUS METRONIDAZOLE AS AN ADJUNCT TO CORTICOSTEROIDS IN SEVERE ULCERATIVE-COLITIS [J]. GUT, 1986, 27 (10) : 1210 - 1212

[10] SHORT CHAIN FATTY-ACIDS IN THE HUMAN-COLON [J]. GUT, 1981, 22 (09) : 763 - 779

[1] [Anonymous], GUT

[2] AZADKHAN AK, 1977, LANCET, V2, P892

[3] BAMBA T, 1995, J GASTROENTEROL, V30, P45

[4] ULCERATIVE-COLITIS AND ESCHERICHIA-COLI WITH ADHESIVE PROPERTIES [J]. JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (07) : 782 - 786

[5] ADHESIVE ESCHERICHIA-COLI IN INFLAMMATORY BOWEL-DISEASE AND INFECTIVE DIARRHEA [J]. BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6641): : 102 - 104

[6] BURKE DA, 1990, ALIMENT PHARM THERAP, V4, P123

[7] Campieri M, 1999, FALK SYMP, V106, P297

[8] Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative? [J]. GASTROENTEROLOGY, 1999, 116 (05) : 1246 - 1249

[9] CONTROLLED TRIAL OF INTRAVENOUS METRONIDAZOLE AS AN ADJUNCT TO CORTICOSTEROIDS IN SEVERE ULCERATIVE-COLITIS [J]. GUT, 1986, 27 (10) : 1210 - 1212

[10] SHORT CHAIN FATTY-ACIDS IN THE HUMAN-COLON [J]. GUT, 1981, 22 (09) : 763 - 779